Cite
HARVARD Citation
Papp, K. et al. (n.d.). A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE). Journal of the European Academy of Dermatology and Venereology. pp. 361-366. [Online].